ZINNAT 125 mg / 5 ml suspension buvable 40 ml
3826/99/18
Id:
2651
CisEQGAB:
0
CisGAB:
61068069
EQSEN:
5792
NumGabon:
2654
ATC:
J01DC02
Dci:
CEFUROXIME
Date_AMM:
30/06/2018
Fin_AMM:
30/06/2023
Titulaire:
GSK